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A B S T R A C T   
Background: Stimulated by the increased recognition of phosphatidylethanol (PEth) as sensitive direct marker of 
alcohol intake, the Ghent University’s Laboratory of Toxicology and the National Institute of Criminalistics and 
Criminology combined their efforts to develop a quantitative method. To facilitate implementation the focus was 
on the use of a sampling technique which allows quick and easy blood collection, without the need of dedicated 
personnel at any place/any time. In the meantime the cooperation of the two labs should also allow to initiate a 
Belgian network of laboratories capable of quantifying PEth. 
Methods: Dried blood microsamples were collected via volumetric absorptive microsampling (VAMS). PEth 16:0/ 
18:1 was quantified after liquid-liquid extraction using two independent isotope dilution - liquid chromatog-
raphy – tandem mass spectrometry methods. A systematic review of the entire process at both sites was per-
formed before the final method comparison using samples from 59 routine toxicology cases collected within a 
one-year time interval. 
Results: Initial differences between both laboratories were solved by focusing on important methodological as-
pects: (i) trueness verification of the calibration protocol focusing on the primary material, preparation of the 
stock solutions and adequate equilibration of calibrators and QCs, and (ii) verification of comparability of results 
obtained with different m/z transitions. Several of these aspects could only be verified by critically assessing 
spiked and native samples. After a final validation good average comparability of the two methods was observed. 
The average bias was − 0.4%, with 85% of the differences within 20%. Moreover, the methods proved to be 
reproducible and robust within a one-year time interval. 
Conclusion: This study is the first to develop a quantitative volumetric absorptive microsampling based method 
for PEth measurements, in addition it is the first to perform a systematic comparison of PEth measurements 
between two laboratories. From the discussion on the encountered pitfalls it is clear that also on a global scale, 
more efforts are needed to improve interlaboratory agreement.   
1. Introduction 
In the quest of finding markers for monitoring long term alcohol 
consumption/abstinence with a higher specificity and sensitivity than 
today’s standards, the usefulness of phosphatidylethanol is increasingly 
being recognized [1–4]. Phosphatidylethanol is a group of phospho-
lipids, formed via the action of the enzyme phospholipase D, but only 
when ethanol is present [5]. The choice of the phosphatidylethanol 
analogue for the research described in this manuscript was based on the 
fact that phosphatidylethanol 16:0/18:1 is the most abundant and most 
commonly measured species [1,2]. In what follows we refer to this 
particular species as “PEth”. PEth has a slow elimination rate with a 
reported half-life of approximately 4–10 days [6,7]. A single drinking 
episode resulting in a blood alcohol concentration of 1 g/L was reported 
to be detectable up to 12 days afterwards [8]. Hence, PEth is a highly 
selective and sensitive marker for alcohol intake, with a sensitivity of 
95% and a specificity of 100% to detect chronic and excessive alcohol 
consumption vs. respectively 77% and 88% for carbohydrate-deficient 
transferrin [9,10]. PEth has the potential to become a key biomarker 
for routine screening in different settings and is already used in forensic 
psychiatry and monitoring programs, and for judging driving ability, the 
* Corresponding author. 
E-mail address: christophe.stove@ugent.be (C.P. Stove).  
Contents lists available at ScienceDirect 
Talanta 
journal homepage: www.elsevier.com/locate/talanta 
https://doi.org/10.1016/j.talanta.2020.121694 
Received 24 June 2020; Received in revised form 17 September 2020; Accepted 21 September 2020   
Talanta 223 (2021) 121694
2
identification of alcohol intake in specific risk groups and for neonatal 
screening of prenatal alcohol exposure [11]. 
With PEth being located at the surface of red blood cells, its mea-
surement requires the collection of whole blood samples [12]. Quick and 
easy blood collection, without the need of dedicated personnel may 
further increase the potential use of this biomarker: samples could be 
drawn at any moment/place. In view of this, fingerprick sampling 
combined with the collection of dried blood spots (DBS), was shown to 
be suitable for the quantitative determination of PEth [9,13]. In addi-
tion, there is an increased interest in the use of devices to volumetrically 
collect dried blood microsamples [14,15]. Best known in this context are 
the Mitra® devices, capable of volumetric absorptive microsampling 
(VAMS), i.e. the volumetric collection of blood by an absorptive tip. 
These devices overcome some limitations related to variability in pro-
cessed sample volume upon taking a sub-punch of a conventional DBS, 
often referred to as the hematocrit effect [16–18]. Moreover, these de-
vices may also offer an advantage from a sampling point of view, by 
increasing the user friendliness, as suggested by feedback obtained from 
VAMS device users [18,19]. 
The Ghent University’s Laboratory of Toxicology (UGent) and the 
National Institute of Criminalistics and Criminology (NICC) recognized 
the potential of PEth as a valuable marker for alcohol intake and set up 
different projects to further evaluate its use. These projects include high 
numbers of study participants and aim at evaluating the applicability of 
PEth, the evaluation of our current in-house decision limits (see Fig. 1) 
and the use of VAMS in different settings (from sampling by study nurses 
and general practitioners to home sampling). The limits are based on 
previous work and reports by international peers [2,9,20], taking into 
account a “grey zone” with respect to the cut-off suggestive for excessive 
alcohol use. The latter gives the benefit of the doubt to the study subject 
and compensates for (i) the measurement uncertainty (as is also foreseen 
in the Belgian legislation for measurements performed in the context of 
driving under the influence of drugs) and (ii) the inconsistency between 
current decision limits. Several variables contribute to this measurement 
uncertainty/inconsistency – part is related to the insufficient compara-
bility of current PEth methods, as can be deduced from the results of the 
Equalis PEth external quality scheme (product code 295, rounds 
2017–2020), in which reported results may differ up to 2-fold, while 
z-scores may still be ‘acceptable’ [21,22]. 
Here, we report on the development and application of PEth 16:0/ 
18:1 measurement procedures in both laboratories, and on how pitfalls 
encountered in getting the results comparable were solved. Method 
comparability was validated using 59 individual donor samples. 
2. Materials and methods 
A detailed description of the chemicals, sample preparation and 
liquid chromatography – tandem mass spectrometry (LC-MS/MS) pro-
cedures applied in both laboratories can be found in supplementary 
data. In short, PEth was extracted from 10-μL VAMS after adding 250 μL 
of extraction solvent and 60 μL methanol containing 25 ng/mL (0.034 
μM) PEth-D5 as internal standard (IS) and shaking (1400 rpm) for 60′ at 
room temperature (RT). The extraction solvent consisted of 2 mM 
ammonium acetate 0.01% formic acid in a 2/8/0.2 water/isopropanol/ 
formic acid mixture. Subsequently, this extract was subjected to liquid- 
liquid extraction (LLE) using 1 mL n-hexane and shaking (1400 rpm) for 
10’ at RT. The n-hexane fraction was collected, dried and reconstituted 
in 50 μL of injection solvent, of which 5 μL was used for the measure-
ment with two completely different LC-MS/MS procedures. For quan-
tification, both methods used m/z 701 → 255. 
2.1. Preparation of calibrators and QCs 
We refer to the supplementary data for a detailed description of the 
preparation of the calibrators and controls, and the verification experi-
ments performed to establish the final protocol. Pipetting of whole blood 
is involved. Therefore, to keep precision/accuracy under control, only 
fresh blood was used and all pipetting steps were done with gravimetric 
control. From a master stock solution of 8 mg/mL (11 mM) PEth 16:0/ 
18:1, working solutions in whole blank blood were prepared with PEth 
concentrations of 10, 20, 50, 100, 250, 500, 1000 and 2000 ng/mL 
(0.014, 0.028, 0.069, 0.138, 0.345, 0.670, 1.38 and 2.76 μM) and in-
ternal quality control (IQC) samples with PEth concentrations of 10, 30, 
500 and 1500 ng/mL (0.014, 0.041, 1.38 and 2.07 μM). For the final 
protocol, spiked samples were equilibrated overnight at 4 ◦C before 
sampling on VAMS. The lower and upper limit of quantification (LLoQ 
and ULoQ), at 10 respectively 2000 ng/ml, were defined based on pre-
vious work [9]. 
External Quality Assessment (EQA) samples were obtained from 
Equalis (Uppsala, Sweden) - rounds 17:03, 18:01 and 18:03 [21]. To 
avoid possible commutability issues (more specifically, the provided 
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Fig. 1. Decision limits currently used at the UGent Laboratory of Toxicology, based on Kummer et al. [9]. The indicated values, expressed in μM limits, are 
respectively 0.014 μM, 0.014–0.028 μM, 0.028–0.21 μM, 0.21–0.37 μM, 0.37–0.69 μM and > 0.69 μM. 
K. Van Uytfanghe et al.                                                                                                                                                                                                                       
Talanta 223 (2021) 121694
3
blood might behave differently from fresh blood when being absorbed 
by the VAMS tips), EQA samples were diluted 1:5 with whole blank 
blood and equilibrated overnight (4 ◦C) before application to VAMS. 
Four different dilution lots were prepared over time. 
2.2. Sample collection 
Blood sample collection was approved by the Ethics Committee of 
Ghent University Hospital (EC UZG 2018/0740 – Registration n◦
B670201836586). Venous blood was obtained from an alcohol abstinent 
healthy person in citrate tubes (BD vacutainer®, 2.7 mL). Mitra™ de-
vices, obtained from Neoteryx® (Torrance, CA), were used to generate 
dried blood samples from the venous whole blood. Samples were pre-
pared by allowing the absorptive tip of the devices to wick up blood, by 
touching the surface of the blood, thereby taking care to prevent over-
filling. After the device was completely filled with blood, contact 
remained for 2 more seconds before the device was placed in the 
accompanying plastic clamshells and dried for 2 h at RT. For longer 
storage the clamshells were put in a zip closure plastic bag containing a 
5 g MiniPax® absorbent packet from Sigma Aldrich (Diegem, Belgium) 
and stored at RT. Multiple series of calibrators and IQC samples were 
sampled at once and stored until further analysis. 
For the method comparison, samples collected from persons in a 
driving license regranting program or samples from routine toxicology 
cases were used. Capillary blood was directly obtained through a fin-
gerprick with a BD® Microtainer (contact-activated lancet). The first 
drop of blood was wiped off, while the second drop was used for sam-
pling. Samples were collected over a one year time interval, with mea-
surements at UGent being performed within a 2–3 weeks’ time interval 
after collection. At the NICC, the samples were measured at the end of 
the sample collection period. Sample storage was as described above. 
2.3. Prevalidation experiments 
In order to investigate initial differences between the methods at 
UGent and NICC, several experiments were performed. These encom-
passed comparison of results for the same extracts (from calibrators, 4 
IQC samples in duplicate, 7 EQA samples in duplicate and 9 native 
samples), analyzed at both sites, to investigate whether observed dif-
ferences were due to the LC-MS/MS method itself. Also the UGent and 
NICC stock solutions were directly compared, by generating 3 inde-
pendent working solutions, which were further diluted with water to 
prepare 3 calibrators (2000 ng/mL (2.76 μM)). Ion ratios (area analyte/ 
area IS) of the UGent and NICC calibrators were compared (Details can 
be found in supplementary data). 
2.4. Method validation 
The method validation covered selectivity, calibration model and 
homoscedasticity, trueness, precision, carry-over, matrix effect, extrac-
tion efficiency and stability. Besides these parameters, which are based 
on U.S. Food and Drug Administration and European Medicines Agency 
guidelines for bioanalytical method validation [23–25], the influence of 
the hematocrit (hct) on the extraction was also investigated, in line with 
the IATDMCT guideline on validation of DBS-based procedures [26]. 
The LLoQ was not determined but was pre-fixed based on the cut-off 
value of alcohol abstinence described in literature (see Fig. 1). Details 
can be found in supplementary data. 
2.5. Method comparison study 
A set of 59 individual donor samples was measured in both labora-
tories. Comparability was evaluated using the criteria generally applied 
for incurred sample reanalysis, i.e. at least two-thirds of the results 
should not deviate more than 20% of their mean [24,25]. Furthermore, 
results were evaluated using Passing Bablok regression and a 
Bland-Altman plot. For the latter, the variation in the %differences 
(expressed as 1.96 times the standard deviation (SD) of the % differ-
ences), should not exceed 29.9% (total error: observed average absolute 
bias + 1.96 * observed average total precision; see Table 3 for the nu-
merical values). To exclude that the difference in time between the 
initial measurement at UGent, and the incurred sample analysis at NICC 
would have an influence on the results, the % deviation was also eval-
uated against the difference in time. 
2.6. Measurement uncertainty 
Measurement uncertainty was calculated following the “Handbook 
for calculation of measurement uncertainty in environmental labora-
tories” and was based on the total precision for the method and a bias 
component derived from the results within the EQA scheme (taking into 
account the bias and its standard deviation) [27,28]. The acceptance 
limit of 42.4% for the measurement uncertainty was propagated based 
on the individual limits for precision and bias (both 15%). 
2.7. Data analysis 
Data analysis was done using Excel and Medcalc statistical software, 
version 14.12.0 (Ostend, Belgium). Statistical tests were performed 2- 
sided, with 95% confidence – unless otherwise stated. 
3. Results 
3.1. Preparation of calibrators and internal quality control samples 
As scouting experiments had revealed that discrepant results for 
authentic VAMS samples were obtained, depending on whether VAMS 
calibrators were prepared from freshly spiked blood vs. blood that was 
allowed to equilibrate with spiked PEth for some time, we systematically 
evaluated this variable. Results obtained with liquid whole blood cali-
brators analyzed immediately after spiking whole blood, or after storage 
for 72 h at 4 ◦C were compared to results obtained with VAMS-based 
calibrators, generated immediately after spiking whole blood, or after 
first equilibrating the blood at 4 ◦C for 1, 8, 24 or 72 h. These revealed no 
significant differences (95% confidence) for blood equilibrated for 1, 8 
and 72 h. For the final protocol the most time efficient option (i.e. 
overnight equilibration) was adopted. The supplementary data contain 
details for both experiments. An impact of incubation time on the 
extractability was also observed by others [29,30]. 
3.2. Method validation 
The methods proved to be selective, as no unacceptable interfering 
peaks were detected in the blank samples (i.e., the blank blood used to 
prepare the calibrators, 4 different donors during the course of the 
validation). For calibration, at UGent, quadratic curves (weighing 1/x2) 
showed the best fit, while at the NICC a linear fit (weighing 1/x) was 
best. The mean back-calculated PEth concentrations were within ±15% 
difference of the nominal values (20% for LLOQ), except for 2 values 
observed in eight calibrations curves at the NICC. 
At UGent, from the signal:noise of the LLoQ (18.4 ± 4.7 (SD), n =
10*2), the LoD was estimated to be 1.7 ng/mL (0.002 μM). At the NICC, 
the LoD was not determined, as (quantitative) results are only reported 
from the LLoQ concentration level onwards. 
There was no signal detected in blanks injected after samples with a 
concentration at the ULoQ. 
The non IS-compensated matrix effect was 79% and 114% at UGent 
and NICC, respectively indicating some suppression and enhancement of 
ionization (Table 1). In both labs, an improvement was seen for the IS- 
compensated matrix effects, at 98% and 109% for UGent and NICC, 
respectively. Importantly, inclusion of the IS also led to a substantial 
improvement of the %RSD values, all being below 8%, which is well 
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within the acceptance limit of 15%. 
Recovery of the analyte over the entire procedure ranged from 44 to 
64% and was consistent within each condition (%RSD < 15%) (Table 2). 
For the low QC, a slight hct dependence was observed, as the IS- 
compensated recovery for the low hct was not within 15% of the re-
covery for samples with a normal hct. For the subjects under study in the 
envisaged application, hct is expected to be within the normal range 
(36–50%) [31]. Hence, in this case there will be no impact. The effi-
ciency of the LLE procedure was on average 75.2% (varying from 71 to 
81%), with no noticeable concentration- or hct-dependence (Table 2). 
PEth was stable in extracts after 72 h of storage in the autosampler at 
4 ◦C (differences ≤ 5.1%; Supplementary Table S2). In VAMS samples, 
stability was demonstrated for at least one week at the three different 
evaluated temperatures (4◦C, RT, and 45◦C) and for one month at RT, as 
deviations did not significantly exceed ±15% (Supplementary 
Figure S3). Furthermore, results for the 4 EQA samples revealed that 
VAMS samples can be stored for at least 400 days at RT, as longitudinal 
analysis of EQA results revealed no discernible trend over time (slope 
not significantly different from 0 (P<0.0001)), the vast majority of the 
PEth results (87%) laying within ±15% of the normalized mean (Fig. 2). 
Note that, taking into account the mean total precision of the method 
(11%) and the bias criterion (15%) – a mean result of 2 duplicates on a 
single day may deviate 35% (= maximum allowable bias + z (2.58) * 
precision/square root of n). None of the results is outside this range. 
Data for bias and precision are summarized in Table 3. Acceptance 
criteria were met at every concentration level, with a single exception 
(total precision at LLoQ for the NICC, at 20.3% narrowly exceeding the 
acceptance criterion of 20%). The expanded measurement uncertainty 
for results obtained by either of the two laboratories, calculated based 
on these results, was 38% (coverage factor k=2), which is below the 
preset specification of 42.4%. 
Fig. 3 shows the results of the method comparison in a scatter plot 
with Passing Bablok regression analysis (A) and in a Bland-Altman Plot 
(B). Both show the good average comparability of the two methods, as 
the slope and intercept are not significantly different from 1 and zero, 
respectively, both having relatively narrow confidence intervals in the 
Passing Bablok curve. On average there was essentially no bias (-0.4%) 
between both methods, the bias at the decision points being 0.9% (at 20 
ng/mL (0.028 μM)) and 3.6% (at 270 ng/mL (0.37 μM)). Results were 
above LoD for 54 samples at Ugent (> 1.7 ng/mL (0.002 μM)) and above 
LLoQ for 51 samples at NICC (LLoQ > 10 ng/mL (0.014 μM)). The pre- 
set acceptance limits (29.9%) for the variation of the %differences (see 
section 2.5) aligned reasonably well with the limits of agreement 
(expressed as 1.96*SD of the %differences) in the Bland-Altman plot, 
suggesting the fit-for-purposeness. This was also underscored by the fact 
that only 15% of the samples had a deviation outside the 20% limit, the 
highest deviations being observed for samples with a concentration 
close to the decision limit (20 ng/mL (0.028 μM)). In our routine prac-
tice, most samples analyzed in the context of driving license regranting 
have (far) higher concentrations (median 181 ng/ml; n = 716). 
Furthermore, Fig. 3C, which gives an overview of the samples scored 
between 9 and 400 ng/mL (0.013–0.55 μM), shows that, overall, taking 
into account the measurement uncertainty and the decision limits 
mentioned in Fig. 1, a consistent scoring would be obtained by both labs. 
Last, no influence of the difference in time between both measurements 
was observed (Fig. 3D). 
4. Discussion 
Stimulated by the increased recognition of PEth as a useful marker 
for alcohol consumption and as a follow-up to our previous research, 
UGent and NICC decided to collaborate, both implementing their own 
method, to initiate a Belgian network of laboratories capable of quan-
titatively determining PEth [1–4,9,18]. Broad applicability of the 
method is guaranteed by utilizing as a starting point a simplified blood 
collection procedure, based on a finger prick. Because VAMS allows a 
fixed volume sampling of blood and because of previous positive expe-
rience, this approach was chosen to collect dried blood microsamples 
[18]. Besides the ease of sample collection, transport and storage, dried 
blood microsampling approaches hold other advantages as well, which 
are particularly relevant for PEth: PEth is very stable in dried blood (in 
contrast to liquid blood) and ex vivo formation of PEth, because of the 
presence of alcohol in blood, can be avoided [32]. This may be an issue 
when blood is not properly stored, giving rise to falsely elevated results 
[22]. 
Both laboratories used the same extraction procedure allowing to 
attain an LLOQ of 10 ng/mL in a robust manner from merely 10 μL of 
blood. The actual measurements were done using two completely 
different LC-MS/MS methods (different LCs, columns and MS instru-
mentation). Initial trueness experiments using EQA and native samples 
revealed a 30% difference between the two laboratories, in contrast to 
comparable results for spiked samples. At first, this was attributed to the 
equilibration of spiked calibrators before their application on VAMS. 
The equilibration experiments suggest that spiked PEth should be given 
time to become incorporated into the membrane of the red blood cells, 
as in native samples. If not, the extraction efficiency of PEth from the 
VAMS is higher for incompletely equilibrated spiked samples compared 
to native samples. This could lead to an underestimation of PEth con-
centrations in real samples, as well as a potential bias between labs. This 
hypothesis is supported by the findings of others [29,30] and by the fact 
that for blood samples (not dried to VAMS), the results obtained for 
native samples are comparable, whether or not PEth spiked to calibrator 
samples was allowed to equilibrate with the red blood cells. Finally, 
calibrators were equilibrated overnight at 4◦C before application to 
VAMS. Confidence in the applied protocol was found in the fact that, 
over one year and 4 different batches of calibrators, results for EQA 
samples were stable (see also Fig. 2). 
Allowing the calibrators to equilibrate did not result in comparable 
data. A further search for the root cause of the observed differences 
pointed at the use of different quantifiers in both laboratories: the 
transition 701 → 255 (UGent) vs. the transition 701 → 281 (NICC). 
When quantified by the transition 701 → 281, results for native samples 
(but not spiked samples, as in the QC’s) are a factor 1.4 (SD 0.09, n=522) 
higher. This remarkable difference is documented by Luginbühl et al. 
and attributable to (i) a different ratio of the PEth 16:0/18:1 to 18:1/ 
16:0 isomers in the reference material versus the naturally occurring 
isomers (16:0/18:1 being more abundant in authentic samples) [33,34], 
Table 1 
Non-IS compensated matrix effects and IS-compensated matrix for QC low and 
QC high.   
UGent NICC 
Low (%) High (%) Low (%) High (%) 
%ME (%RSD) 79.6 (21) 77.8 (16) 119.5 (24) 107.8 (14) 
%MEIS (%RSD) 100 (7.9) 95.9 (5.2) 110.7 (5) 108 (6)  
Table 2 
Recovery and LLE efficiency (mean and %RSD; n = 6).   
%Recovery (%RSD)  
Low hct Normal hct High hct 
Low QC 64.2 (12) 47.6 (14) 43.9 (14) 
High QC 62.5 (14) 64.1 (14) 61.3 (12)  
%IS compensated recovery (%RSD)  
Low hct Normal hct High hct 
Low QC 61.0 (10) 46.6 (9.5) 42.5 (13) 
High QC 54.5 (15) 54.0 (8.1) 58.6 (10)  
%LLE efficiency (%RSD)  
Low hct Normal hct High hct 
Low QC 71.1 (12) 70.6 (11) 79.4 (14) 
High QC 70.8 (14) 78.1 (12) 81.1 (6)  
K. Van Uytfanghe et al.                                                                                                                                                                                                                       
Talanta 223 (2021) 121694
5
and (ii) a different fragmentation efficiency of the side chains of the two 
isomers (the sn-2 position being the preferred fragmentation site (m/z 
281 for PEth 16:0/18:1)) [33,34]. As in high-throughput methods, both 
isomers typically aren’t chromatographically separated, native samples 
might have an ion ratio that is distinct from that observed in calibrators, 
depending on the calibrator chosen [33]. This is an issue that has been 
largely neglected in the literature and can only be solved by reference 
material manufacturers. When both labs used the transition 701 → 255, 
analysis of the same extracts (for both calibrators and samples) resulted 
in an average difference of 1% between both labs, with a SD on the 
differences of 10%. 
Yet, the implementation of this second measure still didn’t result in 
comparable data for samples that were analyzed using independently 
prepared calibration curves. Hence, we directly compared the different 
lab’s stock solutions to exclude that these would result in a calibration 
bias. Three independent working solutions prepared from the stock so-
lutions of the two labs were compared. Observed isotope ratios (%RSD) 
for the UGent solutions were 16.9 (2.4%) vs. 10.0 (3.1%) for the NICC 
solutions, indicating that, although both laboratories used the same 
reference standards, the stock solutions deviated. Rather than searching 
for the root cause of this difference, new and independent stock solu-
tions were made, using the most accurate procedure possible. Using two 
new vials of reference standard (one in each lab), meticulously following 
the protocol described in supplementary data, resolved the issue. This 
protocol involved weighing the original vial before and after transfer of 
the PEth. The rationale behind this was that it is common practice for 
manufacturers to overfill the vials so that the customer receives at least 
the amount of analyte ordered [35]. Hence, taking the nominal weight 
instead of the exact amount could possibly lead to a calibration bias. 
After applying this protocol, the results obtained by both laboratories 
were finally comparable, and the actual method validation and formal 
method comparison could start. 
In both laboratories, the method for quantification of PEth in VAMS 
samples was fully validated and the results showed that, overall, the 
preset quality specifications were met for all investigated aspects. 
Moreover, the obtained LLoQ, recovery and trueness are comparable to 
most recent published PEth 16:0/18:1 methods. Although precision 
seems to be a little higher, it should be noted that most published 
methods started from larger starting volumes of whole blood. Here, the 
starting volume was merely 10 μL of blood, in the format of a dried 
VAMS sample. While we and others have previously demonstrated that 
conventional DBS can be used for PEth analysis, the method reported 
here is the first to quantify PEth, starting from 10 μL VAMS samples. [29, 
36–39]. In a real-world setting, with non-supervised sampling by 
non-trained individuals, the %RSD after application of the entire pro-
cedure (from sampling to analysis) is somewhat higher (14%) than that 
observed here for lab-generated samples (11%), but still acceptable, as 
we reported elsewhere [19]. 
At UGent, the method has been implemented on a weekly basis for 
over a year. During this period, multiple sets of calibration curves and 
EQA lots were prepared and measured. This allowed us to validate the 
method’s robustness as well as the stability of the dried VAMS samples. 
No lot-to-lot variation was observed when evaluating the EQA results, as 
both the precision and trueness proved to be stable over time. 
Combining the data obtained from the evaluation of different calibrator 
lots and EQA lots, made at different time points, also proved the long- 
term stability of PEth in the VAMS devices (Fig. 2). At the same time, 
this also demonstrated the consistent extractability over time, an 
important parameter when dealing with VAMS [40,41]. The excellent 
stability and consistent extractability could also be derived from the 
results of the method comparison, which can also serve as an incurred 
sample reanalysis experiment, with a time difference between the two 
measurements ranging from 30 days up to almost 400 days. In addition, 
the results of the method comparison demonstrated the good compa-
rability of the results, independently obtained by both laboratories, with 
an average difference of -0.4%, and 85% of the samples having a dif-
ference within ±20%, thereby fulfilling the requirement of incurred 
sample reanalysis (i.e. 2/3 of the samples should be within 20% of the 
average). 
The efforts that were required to achieve comparable results between 
only two laboratories made us realize that one should be very careful 
when considering and interpreting published PEth results. Some of the 
observations that were described above would never have been made 
when only using spiked QC samples, as these will always behave in exact 
the same way as spiked calibrators. This potential issue of non- 
commutability between on the one hand spiked calibrators/QCs and 
on the other hand native samples points to the importance of including 
native samples from the initial validation experiments on. In addition, as 
also pointed out by the recent publication of Luginbühl et al., the choice 
Table 3 
Data of bias and precision at the two application sites.   
UGent NICC 
LLoQ L M H EQA1 EQA2 EAQ3 EQA4 Native sample LLoQ L M H 
Concentration (ng/mL) 10 30 500 1500 735 244 465 146 15.7 10 30 50 1500 
Concentration (μM) 0.014 0.041 1.38 2.07 1.01 0.337 0.641 0.201 0.022 0.014 0.041 1.38 2.07 
Number of duplicates 12 15 14 14 36 28 29 33 31 8 8 8 8 
% Biasa 5.2 − 4.5 − 5.5 − 6.5      4.4 − 10.3 − 8.9 8.5 
z-score in EQA     − 1.6 − 2.2 − 1.7 − 1.0      
Within-run precision (%) 7.8 6.2 7.9 5.1 6.9 7.9 8.2 8.6 9.6 15.4 6.2 9.8 7.1 
Between-run precision (%) 10.9 4.8 7.8 10.1 4.8 7.5 7.1 10.8 6.6 13.3 7.0 4.6 5.0 
Total precision (%)a 13.4 7.9 11.1 11.3 8.4 10.9 10.8 13.8 11.7 20.3 9.3 10.8 8.7  
a Results used to calculate the acceptance limits for the 1.96SD of the differences in the method comparison. 
Fig. 2. Overview of EQA results over time. For each EQA sample the results are 
normalized to their mean. The dashed line represents the ±15% overall bias 
limits, the dotted line shows the acceptance limit for a daily mean of duplicate 
measurements (35%). (x) and (*) mark the day where respectively a new 
calibrator lot or new QC lot was started. 
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of the reference standard and the quantifier ion may have an important 
consequence on the numerical value that will be reported [33]. Given 
this discrepancy, and given the judicial framework in which we (like 
many labs that measure PEth) operate, we opted to use the transition 
701 → 255 for quantitation purposes. By doing so, we give the benefit of 
the doubt to the people under investigation. However, the fact that 
different labs may opt to use different transitions, yielding different 
results, also demonstrates the urgent need to standardize PEth quanti-
fication in order to allow more reliable inter-method comparisons and to 
justify the use of common cut-off values. This is yet another reason to 
interpret the results of EQA schemes with utmost care, as we have no 
reference as to which calibrator and which quantifier was used by which 
participant. 
5. Conclusion 
This study is the first to implement PEth quantification based on 
dried blood samples after volumetric microsampling. A technique which 
is highly suitable in the main areas of interest for PEth determination, 
where sampling by untrained professionals, regardless place and time is 
of benefit. Moreover, it is the first to perform a systematic method 
comparison of PEth analysis between 2 different labs. The winding road 
to achieve comparable results points out the important methodological 
aspects that need to be tackled: from trueness verification of the cali-
bration protocol, starting with the primary material and the preparation 
of the stock solutions, over adequate equilibration of the calibrators and 
QCs with spiked PEth, and verification of the comparability of results 
obtained with different m/z transitions. Several of these phenomena can 
only be verified by critically assessing spiked ánd native samples. Up to 
now, to the best of our knowledge, only three other groups briefly 
mention one of the observed phenomena [29,30,34]. The final method 
comparison in this report underpins the suitability of both labs’ methods 
for the intended use. The robustness of the methods and the stability of 
the samples allow to conduct large-scale epidemiological studies, with 
comparable results regardless the time point of sample collection, the 
time point of measurement and even the laboratory. 
Given the worldwide increased interest to use PEth as a primary 
marker for the follow-up of (abstinence from) alcohol use, it is essential 
that also on a global scale more method comparability is achieved. This 
will require a concerted effort, including an increased comparability 
between primary reference materials, and a consensus on which analyte 
should be measured: PEth 16:0/18:1 – with or without separation of 
PEth 18:1/16:0 - or other PEth-analogues, or even the sum of different 
PEth analogues. This will better allow future research to reach a 
consensus on decision limits, discern reliable PEth half-life, etc. In 
addition, further improvement of the reliability of PEth analysis will 
improve the consistency of the values obtained by different laboratories 
(and decrease their uncertainties) and will further strengthen the 
implementation of its use in a variety of contexts. 
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Fig. 3. Comparison of PEth data of 59 authentic samples, measured at UGent and NICC. A, Passing Bablok regression plot: the black line is the regression line, the 
dotted line is the line of equality and the dashed lines represent the 95% confidence interval around the regression line. B, Bland Altman plot: the mean % difference 
is represented by the black line, surrounded by the 95% confidence interval. The limits of agreement (1.96SD of the differences) are indicated by the dashed lines 
(also surrounded by their respective 95% confidence intervals). The dotted lines represent either the ±20% limits and the acceptance limits for 1.96SD of the % 
differences (at ±29.9%). C, % difference plot (sorted per time difference): the dotted lines represent zero or the ±20% limits. D, PEth levels for each method. Both 
results are connected with a line to visualize the effect the use of a different method had on the interpretation of the result. For clarity, the graph only represents all 
data points between 9 and 400 ng/mL (0.013–0.55 μM). Cut-off levels are indicated by dashed lines. The grey rectangles represent the area corresponding to cut-off ±
29.9% total error. 
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